{{Rsnum
|rsid=7175701
|Gene=IL16
|Chromosome=15
|position=81266282
|Orientation=plus
|GMAF=0.2438
|Gene_s=IL16
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.4 | 38.9 | 56.6
| HCB | 0.0 | 5.1 | 94.9
| JPT | 0.0 | 8.0 | 92.0
| YRI | 34.2 | 45.2 | 20.5
| ASW | 17.5 | 56.1 | 26.3
| CHB | 0.0 | 5.1 | 94.9
| CHD | 0.0 | 9.2 | 90.8
| GIH | 3.0 | 23.8 | 73.3
| LWK | 29.1 | 51.8 | 19.1
| MEX | 0.0 | 17.2 | 82.8
| MKK | 19.9 | 42.3 | 37.8
| TSI | 3.9 | 41.2 | 54.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22923025
|Title=Fine-mapping of IL-16 gene and prostate cancer risk in African Americans
|OA=1
}}

{{on chip | Illumina Human 1M}}